Candriam S.C.A. Catalent, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Catalent, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 22,412 shares of CTLT stock, worth $1.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,412

Previous 15,639 43.31%

Holding current value

$1.42 Million

Previous $879,000 54.38%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$56.16 - $60.96 $380,371 - $412,882	6,773 Added 43.31%	22,412 $1.36 Million
Q2 2024 Aug 05, 2024	BUY	$53.58 - $57.02 $97,140 - $103,377	1,813 Added 13.11%	15,639 $879,000
Q1 2024 May 03, 2024	BUY	$42.56 - $59.82 $44,602 - $62,691	1,048 Added 8.2%	13,826 $780,000
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $97,569 - $141,200	3,032 Added 31.11%	12,778 $574,000
Q3 2023 Nov 13, 2023	SELL	$44.2 - $50.2 $112,002 - $127,206	-2,534 Reduced 20.64%	9,746 $443,000
Q2 2023 Aug 08, 2023	SELL	$31.86 - $67.26 $519,636 - $1.1 Million	-16,310 Reduced 57.05%	12,280 $532,000
Q1 2023 May 12, 2023	SELL	$45.44 - $74.26 $2 Million - $3.27 Million	-43,994 Reduced 60.61%	28,590 $1.88 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $1.59 Million - $3.11 Million	38,355 Added 112.05%	72,584 $3.27 Million
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $1.83 Million - $2.85 Million	25,224 Added 280.11%	34,229 $2.48 Million
Q2 2022 Aug 03, 2022	BUY	$87.2 - $114.05 $20,666 - $27,029	237 Added 2.7%	9,005 $966,000
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $175,005 - $231,302	-1,858 Reduced 17.49%	8,768 $972,000
Q4 2021 Feb 10, 2022	BUY	$119.57 - $139.07 $100,438 - $116,818	840 Added 8.58%	10,626 $2.22 Million
Q3 2021 Nov 09, 2021	SELL	$109.17 - $142.35 $3.37 Million - $4.39 Million	-30,830 Reduced 75.91%	9,786 $1.3 Million
Q2 2021 Jul 20, 2021	BUY	$100.34 - $115.69 $3.01 Million - $3.48 Million	30,046 Added 284.26%	40,616 $4.39 Million
Q4 2020 Jan 22, 2021	BUY	$85.88 - $105.36 $105,288 - $129,171	1,226 Added 13.12%	10,570 $1.1 Million
Q2 2020 Jul 23, 2020	BUY	$48.02 - $79.04 $448,698 - $738,549	9,344 New	9,344 $685,000

Others Institutions Holding CTLT

# of Institutions

515

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account